There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, ...

"[Doctors should] be informed that hair loss may be a potential side effect." "With this information, the risk-benefit trad ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Novo Nordisk rejoined the ABPI after a two-year suspension linked to promotional concerns. Audits confirmed compliance with ...

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

Philly patients worry about affording their weight-loss medications as some insurers tighten requirements around coverage.